LN-297833
(9H-fluoren-9-yl)Methyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)aMino)-1-Methoxy-2-Methyl-3-oxopropyl)pyrrolidin-1-yl)-3-Methoxy-5-Methyl-1-oxoheptan-4-yl)(Methyl)aMino)-3-Methyl-1-oxobutan-2-yl)aMino)-3-Met , 98% , 474645-26-6
Update time: 2023-04-23
PRODUCT Properties
| Boiling point: | 1036.4±65.0 °C(Predicted) |
| Density | 1.148±0.06 g/cm3(Predicted) |
| storage temp. | 4°C, stored under nitrogen ,unstable in solution, ready to use. |
| solubility | DMSO : ≥ 45 mg/mL (47.86 mM) |
| form | Solid |
| pka | 13.66±0.20(Predicted) |
| color | White to off-white |
Description and Uses
Fmoc-MMAE is a protective group-conjugated monomethyl auristatin E (MMAE), which is a potent tubulin inhibitor. Fmoc-MMAE can be used in the synthesis of ADC[1].
